How Long Should We Give T-DXd in First-Line HER2+ Breast Cancer?

Not long ago, HER2+ disease carried the worst prognosis. Now we’re talking about 40 months of median PFS—and that changes everything. 🎙️ The Breast Friends Podcast premieres January 20. 🔥 Stay tuned. Big questions. Real answers. #HER2Positive #TDXd #BreastCancer #OncologyPodcast #CancerCare #MedEd #ClinicalOncology #StayTuned